With New Public Offering, Triangle Biotech Scene Hopes For A Win

WUNC News | By Jennifer Brookland ,

Frank Stasio

Published May 24, 2017 at 12:17 PM EDT

Trading Floor at the New York Stock Exchange

It is tough out there for biotech companies. The rewards can be big, but the time frames are long and the risks are high. Research Triangle Park-based G1 Therapeutics is the latest hope for the area’s biotech scene.

WUNC data reporter Jason deBruyn talks about the Triangle biotech scene.

The company went public last week, sparking hope that local investments in the company’s proposed cancer drug pay off. Host Frank Stasio talks with WUNC data reporter Jason deBruyn about what a win would mean for the Triangle’s biotech scene and other industry news.

Jennifer Brookland

Jennifer Brookland is a temporary producer for The State of Things.

See stories by Jennifer Brookland

Frank Stasio

Longtime NPR correspondent Frank Stasio was named permanent host of The State of Things in June 2006. A native of Buffalo, Frank has been in radio since the age of 19. He began his public radio career at WOI in Ames, Iowa, where he was a magazine show anchor and the station's News Director.

See stories by Frank Stasio